Inequity in colorectal cancer treatment and outcomes: a population-based study
2008

Inequity in Colorectal Cancer Treatment and Outcomes

Sample size: 15249 publication 10 minutes Evidence: moderate

Author Information

Author(s): Carsin A-E, Sharp L, Cronin-Fenton D P, Céilleachair A Ó, Comber H

Primary Institution: National Cancer Registry, Ireland

Hypothesis

What factors influence treatment receipt and mortality in colorectal cancer patients?

Conclusion

The study found significant inequities in treatment and outcomes for colorectal cancer, suggesting that improving treatment availability could reduce mortality.

Supporting Evidence

  • 78% of patients had surgical resection, 31% received chemotherapy, and 13% received radiotherapy.
  • Chemotherapy use increased significantly over time, particularly for stage III patients.
  • Older, unmarried patients were less likely to receive chemotherapy and surgery.

Takeaway

This study looked at how people with colorectal cancer are treated and how well they do, finding that some groups get less treatment and have worse outcomes.

Methodology

The study analyzed treatment patterns and mortality factors in 15,249 colorectal cancer patients diagnosed from 1994 to 2002 using logistic regression and Cox proportional hazards models.

Potential Biases

Potential biases include unmeasured confounders affecting treatment decisions and outcomes.

Limitations

The study lacked detailed information on specific chemotherapy regimens and radiotherapy courses, and 40% of cases had incomplete data on T, N, and M status.

Participant Demographics

57% of participants were male, with a distribution of stages: 12% stage I, 25% stage II, 23% stage III, 22% stage IV, and 17% unknown stage.

Statistical Information

P-Value

p<0.05

Confidence Interval

95% CI +8.4, +10.8%

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1038/sj.bjc.6604467

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication